These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 33762162)

  • 1. Suppressing long noncoding RNA OGRU ameliorates diabetic retinopathy by inhibition of oxidative stress and inflammation via miR-320/USP14 axis.
    Fu S; Zheng Y; Sun Y; Lai M; Qiu J; Gui F; Zeng Q; Liu F
    Free Radic Biol Med; 2021 Jun; 169():361-381. PubMed ID: 33762162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-26a-5p Attenuates Oxidative Stress and Inflammation in Diabetic Retinopathy through the USP14/NF-
    Bian J; Ge W; Jiang Z
    J Ophthalmol; 2024; 2024():1470898. PubMed ID: 38282961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of NEAT1 exerts suppressive effects on diabetic retinopathy progression via inactivating TGF-β1 and VEGF signaling pathways.
    Shao K; Xi L; Cang Z; Chen C; Huang S
    J Cell Physiol; 2020 Dec; 235(12):9361-9369. PubMed ID: 32356340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Müller Cells Harboring Exosomal lncRNA OGRU Modulate Microglia Polarization in Diabetic Retinopathy by Serving as miRNA Sponges.
    Fu S; Sun W; Liu L; Xiao J; Xiong J; Hu Y; Zhou Q; Yin X
    Diabetes; 2024 Nov; 73(11):1919-1934. PubMed ID: 39178104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA FLG-AS1 Mitigates Diabetic Retinopathy by Regulating Retinal Epithelial Cell Inflammation, Oxidative Stress, and Apoptosis via miR-380-3p/SOCS6 Axis.
    Luo R; Li L; Xiao F; Fu J
    Inflammation; 2022 Oct; 45(5):1936-1949. PubMed ID: 35461393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA TPTEP1 suppresses diabetic retinopathy by reducing oxidative stress and targeting the miR-489-3p/NRF2 axis.
    Wang X; Zhou X; Wang F; Zhang N; Zhang Y; Ao Z; He F
    Acta Biochim Pol; 2023 Feb; 70(1):45-50. PubMed ID: 36795778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of lncRNA TUG1 alleviates diabetic retinal vascular dysfunction through regulating miR-524-5p/FGFR2.
    Tian M; Yang J; Yan X; Cao Y; Liu Y; Lei Y; Lv H
    Bioengineered; 2022 May; 13(5):12661-12672. PubMed ID: 35599572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of lncRNA-PAX8-AS1-N directly associated with VEGF/TGF-β1/8-OhdG enhances podocyte apoptosis in diabetic nephropathy.
    Shen Y; Tong ZW; Zhou Y; Sun Y; Xie Y; Li R; Liu H
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6864-6872. PubMed ID: 32633379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow mesenchymal stem cells-induced exosomal microRNA-486-3p protects against diabetic retinopathy through TLR4/NF-κB axis repression.
    Li W; Jin L; Cui Y; Nie A; Xie N; Liang G
    J Endocrinol Invest; 2021 Jun; 44(6):1193-1207. PubMed ID: 32979189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA XIST restrains the activation of Müller cells and inflammation in diabetic retinopathy via stabilizing SIRT1.
    Zhang J; Chen C; Zhang S; Chen J; Wu L; Chen Z
    Autoimmunity; 2021 Dec; 54(8):504-513. PubMed ID: 34498499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA-MALAT1 promotes neovascularization in diabetic retinopathy through regulating miR-125b/VE-cadherin axis.
    Liu P; Jia SB; Shi JM; Li WJ; Tang LS; Zhu XH; Tong P
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988072
    [No Abstract]   [Full Text] [Related]  

  • 12. miR-142-5p regulates the progression of diabetic retinopathy by targeting IGF1.
    Liu X; Li J; Li X
    Int J Immunopathol Pharmacol; 2020; 34():2058738420909041. PubMed ID: 32116075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-MYC-activated lncRNA SNHG20 accelerates the proliferation of diffuse large B cell lymphoma via USP14-mediated deubiquitination of β-catenin.
    Wang C; Fu W; Zhang Y; Hu X; Xu Q; Tong X
    Biol Direct; 2024 Jun; 19(1):47. PubMed ID: 38886753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA COL1A2 promotes angiogenesis via regulating miR-29b/VEGF axis in diabetic retinopathy.
    Zou J; Liu KC; Wang WP; Xu Y
    Life Sci; 2020 Sep; 256():117888. PubMed ID: 32497630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circ_0000615 promotes high glucose-induced human retinal pigment epithelium cell apoptosis, inflammation and oxidative stress via miR-646/YAP1 axis in diabetic retinopathy.
    Zeng Q; Luo Y; Fang J; Xu S; Hu YH; Yin M
    Eur J Ophthalmol; 2022 May; 32(3):1584-1595. PubMed ID: 34096368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel regulatory network of linc00174/miR-150-5p/VEGFA modulates pathological angiogenesis in diabetic retinopathy.
    Wang JJ; Wu KF; Wang DD
    Can J Physiol Pharmacol; 2021 Nov; 99(11):1175-1183. PubMed ID: 34081870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA SNHG7 inhibits high glucose-induced human retinal endothelial cells angiogenesis by regulating miR-543/SIRT1 axis.
    Ke N; Pi LH; Liu Q; Chen L
    Biochem Biophys Res Commun; 2019 Jun; 514(2):503-509. PubMed ID: 31056258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. USP14 Regulates ATF2/PIK3CD Axis to Promote Microvascular Endothelial Cell Proliferation, Migration, and Angiogenesis in Diabetic Retinopathy.
    He FT; Fu XL; Li MH; Fu CY; Chen JZ
    Biochem Genet; 2023 Oct; 61(5):2076-2091. PubMed ID: 36939972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA-MEG3 alleviates high glucose induced inflammation and apoptosis of retina epithelial cells via regulating miR-34a/SIRT1 axis.
    Tong P; Peng QH; Gu LM; Xie WW; Li WJ
    Exp Mol Pathol; 2019 Apr; 107():102-109. PubMed ID: 30529346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA myocardial infarction-associated transcript promotes 1-Methyl-4-phenylpyridinium ion-induced neuronal inflammation and oxidative stress in Parkinson's disease through regulating microRNA-221-3p/ transforming growth factor /nuclear factor E2-related factor 2 axis.
    Lang Y; Zhang H; Yu H; Li Y; Liu X; Li M
    Bioengineered; 2022 Jan; 13(1):930-940. PubMed ID: 34967706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.